Abstract:Objective:To explore the efficacy and influencing factors of radiofrequency ablation (RFA) in the treatment of colorectal cancer liver metastases (CRLM).Methods:The clinical and imaging data of 281 patients (477 intrahepatic metastatic tumors) who received percutaneous RFA treatment in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine from December 2009 to December 2020 were retrospectively analyzed. Factors that may affect the efficacy of RFA were recorded, including carcinoembryonic antigen (CEA), differentiation, extrahepatic metastasis, tumor location and size, complications and other information. Patients were followed up through hospital admissions, telephone, etc. The primary endpoints were overall survival (OS) and local tumor progression-free survival (LTPFS). Univariate and multivariate logistic regression models were used to identify predictors of residual tumor. Univariate and multivariate Cox proportional hazards regression were used to identify the influencing factors of LTPFS and OS. The median LTPFS and OS were estimated by the Kaplan-Meier curve and compared by the log-rank test.Results:After RFA, 68 (14.3%) tumor residues were observed. Multivariate logistic regression showed that the risk factors for residual tumor were size ≥20 mm, high-risk and perivascular location, and minimal ablative margin<5 mm. During the follow-up period, the main complication rate was 4.3% (12/281) and the fatality rate was 31.3% (88/281). At the same time, local tumor progression was found in 167 (35.0%) lesions post-RFA. The median time of LTPFS and OS estimated by the Kaplan Meier method were 35.0 (95%CI 26.53-43.48) and 44.0 (95%CI 29.70-58.30) months, respectively. The cumulative proportion of LTPFS and OS were 37.2% and 40.4% respectively in the 5th year. Multivariate Cox proportional hazard regression showed that CEA≥30 ng/ml, tumor size ≥20 mm, and minimal ablative margin<5 mm were risk factors for LTPFS; extrahepatic metastasis, tumor burden>30 mm, and lesion with minimal ablative margin<5 mm were independent risk factors for OS; re-intervention was an independent protective factor for OS.Conclusions:Adequate ablative margin and less tumor burden were beneficial to local tumor control and long-term survival of patients in the RFA treatment; the existence of extrahepatic metastasis was an important risk factor for OS, and re-interventional therapy was beneficial to extend OS.

Margin Size is an Independent Predictor of Local Tumor Progression after Ablation of Colon Cancer Liver Metastases

Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802)

Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases

3D Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural vs 4–8-week Post-ablation Assessment

Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases

Ablative Safety Margin Depicted by Fusion Imaging with Post-Treatment Contrast-Enhanced Ultrasound and Pre-Treatment CECT/CEMRI after Radiofrequency Ablation for Liver Cancers.

Analysis of therapeutic effect and influencing factors of radiofrequency ablation for colorectal cancer liver metastases

Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation

Are All Local Tumour Progressions of HCC Related to Thermal Ablation? A Study of the Causes and Classification of Local Tumour Progression.

Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging

Learning Curve of Microwave Ablation for Liver Cancers

Periprocedural Risk Factors for Incomplete Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: a Single-Center Retrospective Analysis

Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables

Analysis of Survival Factors after Hepatic Resection for Colorectal Cancer Liver Metastases: Does the R1 Margin Matter?

The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases

Does Primary Tumor Location Impact the Prognosis of Colorectal Liver Metastases Patients after Microwave Ablation? - Lessons from 10 Years’ Experience

Local Tumor Progression After Ultrasound-Guided Percutaneous Microwave Ablation Of Stage T1a Renal Cell Carcinoma: Risk Factors Analysis Of 171 Tumors

Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis

Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases

Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success

Does the Site of the Primary Affect Outcomes when Ablating Colorectal Liver Metastases with Radiofrequency Ablation?